Cipla Ltd

Levolin 0.63mg Respule 5X2.5ml

MRP ₹32.46 (Inclusive of all taxes)
Deliver to

    Netmeds First Membership

    Starting at just ₹[] for 3 months.
    View Plans

    Introduction About LEVOLIN 0.63MG RESPULE

    LEVOLIN 0.63MG RESPULE contains Levosalbutamol which belongs to the group of medicines called Bronchodilators. It is indicated in the management or management of bronchospasm (constriction of airways) in adults, adolescents, and children between 6-11 years old with reversible obstructive airway disease.

    Your doctor might ask you to take several diagnostic tests before starting the management with LEVOLIN 0.63MG RESPULE.

    It should be used with caution in patients having cardiovascular disorders (coronary insufficiency, cardiac arrhythmias, and high blood pressure), kidney diseases, epilepsy, overactive thyroid gland, and diabetes.

    Caution must be exercised while using LEVOLIN 0.63MG RESPULE in pregnant and breast-feeding women. Consult with your doctor before using.

    LEVOLIN 0.63MG RESPULE is not recommended for use in children below 6 years of age. Consult your doctor immediately if you experience any side effects.

    Uses Of LEVOLIN 0.63MG RESPULE

    • Used to manage bronchospasm (constriction of airways) in reversible obstructive airway disease

    How LEVOLIN 0.63MG RESPULE Works

    LEVOLIN 0.63MG RESPULE helps in the management of bronchospasm acts by relaxing smooth muscle in the bronchial tubes (airway) to increase air flow and relieve shortness of breath by activation of an enzyme which inhibits the release of cells called mast cells which are responsible for causing asthma.

    How to use LEVOLIN 0.63MG RESPULE

    Use LEVOLIN 0.63MG RESPULE as advised by your physician. It is for oral inhalational use only. It is administered by nebulisation using with nebuliser (with a face mask or mouthpiece) which is connected to an air compressor. Your doctor will guide on how to use the nebuliser. Do not exceed the recommended dose of LEVOLIN 0.63MG RESPULE. Check the label for directions before use.

    Your doctor will decide the correct dose and duration of LEVOLIN 0.63MG RESPULE for you depending upon your age, body weight and disease condition.

    Side Effects Of LEVOLIN 0.63MG RESPULE

    Rare

    Stop using LEVOLIN 0.63MG RESPULE and inform your doctor immediately if you experience any of the following side effects:

    • sudden shortness of breath (constriction of airways)
    • asthma getting worsen
    • severe allergic rection presenting as swelling of the face, throat or tongue, hives, rash, breathing problems
    • heart problems (changes in heart rate or blood pressure)
    • low potassium levels in blood

    Warning & Precautions

    Pregnancy

    LEVOLIN 0.63MG RESPULE should be used with caution in pregnant women or women planning to have a baby as safety and effectiveness to the baby and mother has not been established yet. Dose will be adjusted by your doctor. Consult your doctor before using it.

    Breastfeeding

    LEVOLIN 0.63MG RESPULE should be used with caution in breastfeeding women as it is not known if LEVOLIN 0.63MG RESPULE passes through mother’s milk. Consult your doctor before using it.

    Kidney

    LEVOLIN 0.63MG RESPULE should be used with caution in patients with kidney problems. Consult your doctor before using it.

    Allergy

    Do not use LEVOLIN 0.63MG RESPULE if you are allergic to Levosalbutamol or any other ingredients of this medicine.

    Heart Disease

    LEVOLIN 0.63MG RESPULE should be used with caution in patients with heart diseases such as coronary insufficiency, irregular heartbeat, and high blood pressure. Consult your doctor before using.

    Others

    Before using LEVOLIN 0.63MG RESPULE tell your doctor if you have:

    • epilepsy
    • thyroid problems
    • diabetes

    Use in pediatrics:

    LEVOLIN 0.63MG RESPULE has not been shown to be safe and effective in children younger than 6 years of age. Consult your doctor before using.

    Use in geriatrics:

    Your doctor will decide the correct dose and duration of the management with LEVOLIN 0.63MG RESPULE for you depending upon your age, health condition and body weight. Kidney function will be monitored. Consult your doctor before using.

    Interactions

    A. Drug–Drug Interactions:

    Before using LEVOLIN 0.63MG RESPULE inform your doctor if you are taking any of the following medicine:

    • other short acting bronchodilators such as albuterol, terbutaline (used to manage asthma)
    • beta blockers such as metoprolol, propranolol (used to manage irregular heartbeat)
    • digoxin (used to manage heart diseases)
    • diuretics (water medicines) such as furosemide, chlorothiazide
    • isocarboxazid, tricyclic antidepressants such as nortriptyline, amitriptyline (used to manage depression)
    • halothane, enflurane, isoflurane, desflurane, sevoflurane (used as anaesthetics)
    • corticosteroids (anti-inflammatory drug Ex. dexamethasone, hydrocortisone)

    Overdosage:

    If you or anyone else accidentally use too much of LEVOLIN 0.63MG RESPULE, consult your doctor immediately or visit the nearby hospital. The symptoms of overdosage of LEVOLIN 0.63MG RESPULE are fastened heart rate, nervousness, headache, tremor, dry mouth, palpitation, nausea, dizziness, fatigue, and sleeplessness.

    Synopsis

    Drug :   Levosalbutamol
    Pharmacological Category :   Beta Agonists
    Therapeutic Indication :   Bronchospasm in Reversible Obstructive Airway Disease         
    Dosage Forms :   Tablet, Syrup, Transpules, Respules, Solution, Rotacaps, Inhalers, Nexhalers, Inhalation solution

    More Information

    • Keep LEVOLIN 0.63MG RESPULE out of reach of children
    • Store below at room temperature 30°C

    FAQs About LEVOLIN 0.63MG RESPULE

    Q: What is Levolin 0.63mg Respule and why is it prescribed?

    A: Levolin 0.63mg Respule contains Levosalbutamol, which belongs to a group of medicines called bronchodilators. It is prescribed for the management of bronchospasm (narrowing of the airways) in adults, adolescents, and children aged 6-11 years with reversible obstructive airway diseases such as asthma. It works by relaxing the airway muscles, making breathing easier.

    Q: Can Levolin 0.63mg Respule be given to patients having heart disease?

    A: Levolin 0.63mg Respule may cause a faster heart rate. It should be used with caution in patients with heart conditions such as coronary insufficiency, irregular heartbeat (arrhythmia), or high blood pressure. Always consult your doctor before using this medicine if you have any heart disease.

    Q: Is it safe to use Levolin 0.63mg Respule in diabetic patients?

    A: Levolin 0.63mg Respule may cause an increase in blood sugar levels. Therefore, diabetic patients should use it with caution and remain under close medical observation. Consult your doctor before starting this medicine.

    Q: How to use Levolin 0.63mg Respule?

    A: Use Levolin 0.63mg Respule as advised by your physician. It is for oral inhalational use only. It is administered by nebulisation using with nebuliser (with a face mask or mouthpiece) which is connected to an air compressor. Your doctor will decide the correct dose and duration of Levolin 0.63mg Respule for you depending upon your age, body weight and disease condition.

    Q: Can I stop using Levolin 0.63mg Respule if I feel better?

    A: No, you should not stop using Levolin 0.63mg Respule on your own, even if you feel better. Continue using it for the entire duration prescribed by your doctor. If you wish to stop or have concerns, consult your doctor for proper guidance.

    References

    1. K.D. Tripathi. Respiratory System Drugs. Essentials of medical pharmacology. Seventh edition. 2013. Page – 222.

    2. Mukesh Kumar Gupta, Meenu Singh. Evidence based review on Levosalbutamol. NIH National Library of Medicine, National centre for biotechnology information. Pubmed.gov. February 2007. [Accessed on 24th February 2026]

    3. J L Schlienger, M J Compagnie, P Dellenbach, F Stephan. Metabolic risks of salbutamol in diabetic patients. A study using somatostatin (author's transl). NIH National Library of Medicine, National centre for biotechnology information. Pubmed.gov. September 1980. [Accessed on 24th February 2026]

    4. NIH National Library of Medicine, National centre for biotechnology information. Pubchem. Levalbuterol. [Accessed on 24th February 2026]

    5. Drugbank. Levosalbutamol. [Revised in October 2021] [Accessed on 24th February 2026]

    Author Details

    Written By Dr. Janet.C - Pharm.D
    Reviewed For Accuracy By Dr. Rajnikant - MBBS, MD (Physiology)
    Last updated on 26 Mar 2024 | 03:53 PM(IST)
    Lab updated